These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 33514009)

  • 1. Co-Amorphous Formulations of Furosemide with Arginine and P-Glycoprotein Inhibitor Drugs.
    Ruponen M; Kettunen K; Santiago Pires M; Laitinen R
    Pharmaceutics; 2021 Jan; 13(2):. PubMed ID: 33514009
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dissolution and Permeability Properties of Co-Amorphous Formulations of Hydrochlorothiazide.
    Ruponen M; Rusanen H; Laitinen R
    J Pharm Sci; 2020 Jul; 109(7):2252-2261. PubMed ID: 32315662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT; Blaabjerg LI; Lenz E; Bohr A; Grohganz H; Kleinebudde P; Rades T; Löbmann K
    J Pharm Pharmacol; 2016 May; 68(5):615-24. PubMed ID: 26245703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permeability of glibenclamide through a PAMPA membrane: The effect of co-amorphization.
    Ruponen M; Visti M; Ojarinta R; Laitinen R
    Eur J Pharm Biopharm; 2018 Aug; 129():247-256. PubMed ID: 29894814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of variation in molar ratio on co-amorphous drug-amino acid systems.
    Jensen KT; Larsen FH; Löbmann K; Rades T; Grohganz H
    Eur J Pharm Biopharm; 2016 Oct; 107():32-9. PubMed ID: 27368747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of co-amorphization of glibenclamide on its dissolution properties and permeability through an MDCKII-MDR1 cell layer.
    Sormunen H; Ruponen M; Laitinen R
    Int J Pharm; 2019 Oct; 570():118653. PubMed ID: 31472218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spray drying of poorly soluble drugs from aqueous arginine solution.
    Ojarinta R; Lerminiaux L; Laitinen R
    Int J Pharm; 2017 Oct; 532(1):289-298. PubMed ID: 28890173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of an amorphous sodium furosemide salt improves solubility and dissolution rate and leads to a faster Tmax after oral dosing to rats.
    Nielsen LH; Gordon S; Holm R; Selen A; Rades T; Müllertz A
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):942-51. PubMed ID: 24075980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K; Grohganz H; Laitinen R; Strachan C; Rades T
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):873-81. PubMed ID: 23537574
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
    Lu W; Rades T; Rantanen J; Yang M
    Int J Pharm; 2019 Jun; 565():1-8. PubMed ID: 30999050
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions.
    Dengale SJ; Ranjan OP; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K
    Eur J Pharm Sci; 2014 Oct; 62():57-64. PubMed ID: 24878386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan.
    Huang Y; Zhang Q; Wang JR; Lin KL; Mei X
    Pharm Dev Technol; 2017 Feb; 22(1):69-76. PubMed ID: 27050301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and Evaluation of Co-amorphous Formulations of Telmisartan-Amino Acids as a Potential Method for Solubility and Dissolution Enhancement.
    Khanfar M; Al-Remawi M; Al-Akayleh F; Hmouze S
    AAPS PharmSciTech; 2021 Mar; 22(3):112. PubMed ID: 33748914
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Co-Amorphous Screening for the Solubility Enhancement of Poorly Water-Soluble Mirabegron and Investigation of Their Intermolecular Interactions and Dissolution Behaviors.
    An JH; Lim C; Kiyonga AN; Chung IH; Lee IK; Mo K; Park M; Youn W; Choi WR; Suh YG; Jung K
    Pharmaceutics; 2018 Sep; 10(3):. PubMed ID: 30189645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of co-former performance in co-amorphous formulations: Single amino acids, amino acid physical mixtures, amino acid salts and dipeptides as co-formers.
    Wu W; Grohganz H; Rades T; Löbmann K
    Eur J Pharm Sci; 2021 Jan; 156():105582. PubMed ID: 33039568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of Amorphous and Co-Amorphous Simvastatin Formulations Prepared by Spray Drying.
    Craye G; Löbmann K; Grohganz H; Rades T; Laitinen R
    Molecules; 2015 Dec; 20(12):21532-48. PubMed ID: 26633346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V; Tajber L; Corrigan OI; Healy AM
    Mol Pharm; 2011 Apr; 8(2):532-42. PubMed ID: 21323367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabrication, solid state characterization and bioavailability assessment of stable binary amorphous phases of Ritonavir with Quercetin.
    Dengale SJ; Hussen SS; Krishna BS; Musmade PB; Gautham Shenoy G; Bhat K
    Eur J Pharm Biopharm; 2015 Jan; 89():329-38. PubMed ID: 25542681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Co-amorphous technology to improve dissolution and physical stability of silybin].
    Liu H; Zhao GW; Jiang QY; Liang XL; Ouyang LQ; Ding HB; Chen XL; Liao ZG
    Zhongguo Zhong Yao Za Zhi; 2022 Jan; 47(1):103-110. PubMed ID: 35178916
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of preparation technique on co-amorphization of carvedilol with acidic amino acids.
    Mishra J; Löbmann K; Grohganz H; Rades T
    Int J Pharm; 2018 Dec; 552(1-2):407-413. PubMed ID: 30278256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.